March 19 (Reuters) - Race Oncology Ltd RAC.AX :
* ENTERS COLLABORATIVE PRECLINICAL RESEARCH PROGRAM WITH UNIVERSITY OF NEWCASTLE
* AGREEMENT TO EXPLORE USE OF BISANTRENE AS A NOVEL FTO DIRECTED TREATMENT FOR MELANOMA
March 19 (Reuters) - Race Oncology Ltd RAC.AX :
* ENTERS COLLABORATIVE PRECLINICAL RESEARCH PROGRAM WITH UNIVERSITY OF NEWCASTLE
* AGREEMENT TO EXPLORE USE OF BISANTRENE AS A NOVEL FTO DIRECTED TREATMENT FOR MELANOMA